XVIIIth annual symposium Strasbourg-Berkeley-Descartes
DRUG PRICING AND INNOVATION IN A NEW GEOPOLITICAL ERA
Strasbourg, June 2026, Thursday. the 18th, 3.PM to 5.30 PM
Welcome by
Esther KELLENBERGER
Dean, School of Pharmacy, University of Strasbourg
NEW DRUGS PRICING : MFN VS. TARIFFS ?
Francis MEGERLIN
Professor, Health Laws & Systemics, University of Strasbourg
Senior Fellow, Berkeley Center for Health Technology, UC Berkeley
MOST FAVORED NATION DRUG PRICING
James C. ROBINSON
Professor emeritus, Health Economics, UC Berkeley, California
Director, Berkeley Center for Health Technology (BCHT)
EUROPE : USHERING IN A NEW ERA
Nicolas SCHLUMBERGER
Director, Market Access, Sanofi France & member, Task Force MFN globale
with
Filippo DRAGO
Professor, University of Catania, Italy & Director, CERD, university of Catania
Heiner HAUG
Director, Innovation Access & Territorial Strategy, Astra Zeneca France
Past-chairman HTA Committee LEEM
François LHOSTE
Professor (h) University Paris Descartes
Past-chairman, Société française d’économie de la santé (SFES)